Our results demonstrate that LRRC1 upregulates the key pro-angiogenic mediator VEGFA via the USP7/PDK1/AKT/GSK3β/β-catenin signaling pathway, promoting angiogenesis in HCC. Here, LRRC1 is linked to hepatocellular carcinoma.